# Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

> **NCT07203287** · PHASE4 · RECRUITING · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 490 (estimated)

## Conditions studied

- Post Operative Pulmonary Complications
- Neuromuscular Blockade
- General Anesthesia

## Interventions

- **DRUG:** Rocuronium
- **DRUG:** Cisatracurium
- **DRUG:** Sugammadex
- **DRUG:** Neostigmine

## Key facts

- **NCT ID:** NCT07203287
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-26
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-08-26
- **Target enrollment:** 490 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07203287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07203287, "Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07203287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*